Valeant Pharmaceuticals International Inc. (NYSE: VRX) confirmed its $1 billion acquisition of Sprout Pharmaceuticals Inc. today...
Valeant Pharmaceuticals International Inc. (NYSE: VRX) and activist investor Bill Ackman announced an unsolicited takeover...